
Shanghai Pharmaceuticals Holding Co., Ltd
SSE:601607.SS
17.84 (CNY) • At close June 16, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 275,250.935 | 260,295.089 | 231,981.3 | 215,824.259 | 191,909.156 | 186,565.796 | 159,084.397 | 130,847.182 | 120,764.66 | 105,516.587 | 92,398.894 | 78,222.817 | 68,078.118 | 54,899.873 | 37,411.066 | 19,568.124 | 16,547.825 | 13,919.791 | 11,410.299 | 10,699.341 | 10,814.95 | 9,785.804 | 7,235.687 | 5,202.034 | 4,595.254 | 4,529.932 | 4,413.391 | 339.812 | 320.967 | 337.354 | 241.25 | 225.701 |
Cost of Revenue
| 244,619.261 | 228,966.947 | 201,494.923 | 187,281.149 | 164,473.961 | 159,751.67 | 136,521.469 | 114,122.683 | 106,530.891 | 92,715.328 | 80,994.124 | 67,980.142 | 58,792.601 | 46,882.192 | 30,619.948 | 17,851.804 | 15,101.389 | 12,697.797 | 10,618.283 | 9,997.308 | 9,794.001 | 8,774.877 | 6,215.342 | 4,491.685 | 4,003.788 | 3,970.005 | 3,886.703 | 291.773 | 270.367 | 291.901 | 205.825 | 193.763 |
Gross Profit
| 30,631.674 | 31,328.142 | 30,486.377 | 28,543.11 | 27,435.195 | 26,814.127 | 22,562.928 | 16,724.499 | 14,233.77 | 12,801.259 | 11,404.769 | 10,242.675 | 9,285.517 | 8,017.681 | 6,791.118 | 1,716.32 | 1,446.436 | 1,221.994 | 792.015 | 702.033 | 1,020.949 | 1,010.927 | 1,020.346 | 710.35 | 591.466 | 559.928 | 526.689 | 48.039 | 50.6 | 45.454 | 35.425 | 31.938 |
Gross Profit Ratio
| 0.111 | 0.12 | 0.131 | 0.132 | 0.143 | 0.144 | 0.142 | 0.128 | 0.118 | 0.121 | 0.123 | 0.131 | 0.136 | 0.146 | 0.182 | 0.088 | 0.087 | 0.088 | 0.069 | 0.066 | 0.094 | 0.103 | 0.141 | 0.137 | 0.129 | 0.124 | 0.119 | 0.141 | 0.158 | 0.135 | 0.147 | 0.142 |
Reseach & Development Expenses
| 2,394.434 | 2,204.034 | 2,112.198 | 1,987.278 | 1,656.671 | 1,349.504 | 1,060.771 | 790.349 | 670.55 | 617.691 | 512.324 | 454.71 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 1,768.885 | 1,712.534 | 1,196.67 | 1,409.457 | 1,320.488 | 1,381.489 | 1,184.145 | 1,513.453 | 1,281.716 | 1,202.665 | 1,131.815 | 1,082.846 | 1,097.323 | 912.563 | 885.747 | 430.048 | 352.286 | 309.982 | 259.78 | 252.706 | 396.592 | 353.259 | 491.955 | 331.48 | 237.395 | 216.66 | 199.089 | 15.099 | 15.925 | 12.014 | 6.43 | 5.778 |
Selling & Marketing Expenses
| 7,765.6 | 9,186.805 | 14,278.975 | 13,318.033 | 12,864.844 | 12,855.723 | 11,058.099 | 7,411.262 | 6,067.497 | 5,348.23 | 4,826.367 | 4,407.225 | 3,972.605 | 3,288.687 | 3,006.095 | 657.419 | 719.807 | 625.499 | 357.669 | 363.475 | 506.185 | 480.451 | 338.897 | 199.866 | 166.616 | 156.348 | 175.323 | 3.721 | 3.896 | 2.876 | 1.947 | 0.786 |
SG&A
| 9,534.486 | 19,768.07 | 15,475.645 | 14,727.49 | 14,185.332 | 14,237.212 | 12,242.244 | 8,924.715 | 7,349.214 | 6,550.895 | 5,958.182 | 5,490.071 | 5,069.928 | 4,201.25 | 3,891.841 | 1,087.467 | 1,072.093 | 935.481 | 617.449 | 616.18 | 902.777 | 833.71 | 830.852 | 531.346 | 404.011 | 373.007 | 374.411 | 18.82 | 19.821 | 14.89 | 8.376 | 6.564 |
Other Expenses
| 10,562.041 | 1,688.803 | 4,117.533 | 3,901.403 | 3,455.402 | 3,297.779 | 144.35 | -23.348 | 484.552 | 522.883 | 547.926 | 185.18 | 271.571 | 187.733 | 183.645 | -12.301 | 39.764 | 25.242 | 43.872 | 61.034 | 69.569 | 55.107 | 36.629 | 7.558 | 9.304 | 9.626 | 22.021 | 22.72 | -0.268 | 0.35 | 1.365 | 0.651 |
Operating Expenses
| 22,490.961 | 23,660.907 | 21,705.375 | 20,616.171 | 19,297.405 | 18,884.495 | 16,326.265 | 11,747.009 | 9,972.305 | 8,846.077 | 8,010.419 | 7,340.957 | 6,617.64 | 5,584.284 | 4,909.409 | 1,112.351 | 1,095.34 | 956.414 | 629.966 | 631.97 | 925.195 | 850.257 | 843.147 | 544.31 | 413.145 | 379.309 | 380.497 | 20.444 | 20.82 | 15.616 | 9.08 | 6.649 |
Operating Income
| 8,140.713 | 7,667.235 | 9,014.65 | 8,205.486 | 7,184.388 | 8,927.615 | 5,208.332 | 5,228.157 | 4,207.101 | 3,686.61 | 3,269.544 | 3,074.308 | 2,795.881 | 2,873.728 | 2,076.567 | 370.748 | 163.638 | 122.604 | 84.576 | 61.216 | 150.111 | 219.52 | 191.616 | 203.341 | 218.446 | 137.51 | 89.946 | 30.641 | 18.106 | 21.361 | 23.019 | 23.662 |
Operating Income Ratio
| 0.03 | 0.029 | 0.039 | 0.038 | 0.037 | 0.048 | 0.033 | 0.04 | 0.035 | 0.035 | 0.035 | 0.039 | 0.041 | 0.052 | 0.056 | 0.019 | 0.01 | 0.009 | 0.007 | 0.006 | 0.014 | 0.022 | 0.026 | 0.039 | 0.048 | 0.03 | 0.02 | 0.09 | 0.056 | 0.063 | 0.095 | 0.105 |
Total Other Income Expenses Net
| -120.706 | -612.938 | -206.297 | -61.671 | -8.906 | 48.52 | 135.046 | -23.348 | 252.887 | 485.244 | 530.188 | 151.331 | 291.846 | 655.47 | -9.143 | -249.326 | 23.07 | -88.961 | -61.823 | 37.508 | 40.689 | 38.356 | 21.861 | -1.001 | -6.201 | 0.43 | 1.095 | -34.266 | -0.249 | 0.208 | 1.181 | -0.236 |
Income Before Tax
| 8,020.007 | 7,054.297 | 8,808.353 | 8,143.815 | 7,175.483 | 6,262.467 | 5,343.378 | 5,204.809 | 4,638.997 | 4,171.854 | 3,799.732 | 3,260.846 | 3,087.727 | 3,035.102 | 2,172.537 | 354.957 | 186.707 | 146.55 | 101.474 | 98.724 | 190.8 | 257.876 | 213.477 | 202.34 | 222.279 | 137.94 | 109.578 | 29.676 | 17.857 | 21.57 | 24.199 | 23.426 |
Income Before Tax Ratio
| 0.029 | 0.027 | 0.038 | 0.038 | 0.037 | 0.034 | 0.034 | 0.04 | 0.038 | 0.04 | 0.041 | 0.042 | 0.045 | 0.055 | 0.058 | 0.018 | 0.011 | 0.011 | 0.009 | 0.009 | 0.018 | 0.026 | 0.03 | 0.039 | 0.048 | 0.03 | 0.025 | 0.087 | 0.056 | 0.064 | 0.1 | 0.104 |
Income Tax Expense
| 2,149.995 | 1,887.726 | 1,816.339 | 1,869.245 | 1,570.219 | 1,431.725 | 887.117 | 1,147.029 | 809.284 | 807.486 | 807.717 | 634.228 | 627.139 | 589.072 | 393.552 | 91.475 | 57.273 | 51.074 | 40.281 | 25.889 | 52.291 | 50.395 | 50.253 | 27.57 | 17.625 | 27.103 | 19.751 | 0.989 | 2.647 | 3.221 | 3.599 | 3.556 |
Net Income
| 4,552.528 | 3,768 | 5,617.152 | 5,093.467 | 4,496.217 | 4,080.994 | 3,881.063 | 3,520.646 | 3,196.395 | 2,876.989 | 2,591.129 | 2,242.925 | 2,052.872 | 2,042.238 | 1,368.253 | 173.333 | 81.983 | 66.278 | 68.71 | 50.523 | 93.135 | 154.446 | 125.847 | 145.281 | 184.837 | 94.426 | 78.734 | 28.687 | 15.21 | 18.348 | 20.6 | 19.87 |
Net Income Ratio
| 0.017 | 0.014 | 0.024 | 0.024 | 0.023 | 0.022 | 0.024 | 0.027 | 0.026 | 0.027 | 0.028 | 0.029 | 0.03 | 0.037 | 0.037 | 0.009 | 0.005 | 0.005 | 0.006 | 0.005 | 0.009 | 0.016 | 0.017 | 0.028 | 0.04 | 0.021 | 0.018 | 0.084 | 0.047 | 0.054 | 0.085 | 0.088 |
EPS
| 1.23 | 1.02 | 1.61 | 1.79 | 1.58 | 1.44 | 1.37 | 1.31 | 1.19 | 1.07 | 0.96 | 0.82 | 0.76 | 0.84 | 0.73 | 0.65 | 0.14 | 0.12 | -0.08 | 0.089 | 0.16 | 0.24 | 0.22 | 0.25 | 0.34 | 0.2 | 0.12 | 0.13 | 0.055 | 0.067 | 0.075 | 0.041 |
EPS Diluted
| 1.23 | 1.02 | 1.61 | 1.79 | 1.58 | 1.44 | 1.37 | 1.31 | 1.19 | 1.07 | 0.96 | 0.82 | 0.76 | 0.84 | 0.73 | 0.65 | 0.14 | 0.12 | -0.08 | 0.089 | 0.16 | 0.24 | 0.22 | 0.25 | 0.34 | 0.2 | 0.12 | 0.13 | 0.055 | 0.067 | 0.075 | 0.041 |
EBITDA
| 12,075.274 | 10,904.982 | 12,255.734 | 10,547.751 | 9,939.626 | 9,345.728 | 6,722.369 | 6,424.177 | 5,162.066 | 4,978.858 | 4,618.66 | 3,852.693 | 3,786.38 | 3,720.221 | 2,635.822 | 2,492.312 | 449.781 | 416.546 | 255.224 | 218.893 | 288.478 | 362.423 | 316.349 | 263.514 | 303.235 | 223.993 | 154.481 | 27.595 | 29.78 | 29.838 | 26.346 | 25.288 |
EBITDA Ratio
| 0.044 | 0.042 | 0.053 | 0.049 | 0.052 | 0.05 | 0.042 | 0.049 | 0.043 | 0.047 | 0.05 | 0.049 | 0.056 | 0.068 | 0.07 | 0.127 | 0.027 | 0.03 | 0.022 | 0.02 | 0.027 | 0.037 | 0.044 | 0.051 | 0.066 | 0.049 | 0.035 | 0.081 | 0.093 | 0.088 | 0.109 | 0.112 |